MS-275 Sensitizes TRAIL-Resistant Breast Cancer Cells, Inhibits Angiogenesis and Metastasis, and Reverses Epithelial-Mesenchymal Transition in Vivo

Molecular Cancer Therapeutics - United States
doi 10.1158/1535-7163.mct-10-0582
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

GATA3 Inhibits Breast Cancer Metastasis Through the Reversal of Epithelial-Mesenchymal Transition

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2010English

miR‑30a Inhibits Epithelial‑mesenchymal Transition and Metastasis in Triple‑negative Breast Cancer by Targeting ROR1

Oncology Reports
MedicineCancer ResearchOncology
2018English

Zoledronic Acid Reverses the Epithelial-Mesenchymal Transition and Inhibits Self-Renewal of Breast Cancer Cells Through Inactivation of NF- B

Molecular Cancer Therapeutics
Cancer ResearchOncology
2013English

Epithelial-Mesenchymal Transition—A Hallmark of Breast Cancer Metastasis

Cancer Hallmarks
2013English

Cx32 Reverses Epithelial-Mesenchymal Transition in Doxorubicin-Resistant Hepatocellular Carcinoma

Oncology Reports
MedicineCancer ResearchOncology
2017English

Lentiviral Vector Mediated Claudin1 Silencing Inhibits Epithelial to Mesenchymal Transition in Breast Cancer Cells

Viruses
VirologyInfectious Diseases
2015English

miR-573 Inhibits Prostate Cancer Metastasis by Regulating Epithelial-Mesenchymal Transition

Oncotarget
Oncology
2015English

MDM2 Promotes Epithelial–mesenchymal Transition and Metastasis of Ovarian Cancer SKOV3 Cells

British Journal of Cancer
Cancer ResearchOncology
2017English

Interleukin-6 Induces Epithelial-Mesenchymal Transition in Breast Cancer Cells

Gaceta Mexicana de Oncolog�a
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy